SRSaad Rashid

Saad Rashid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saad Rashid has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trends in Chronic Myeloid Leukemia Mortality by Race, Age, and Gender in the United States Between 1999 and 2020

    by Saad Rashid, Abhinav Kakuturu, Zeeshan Muzammil, Heena Parkash

    Background and objective Chronic myeloid leukemia (CML) represents a significant portion of leukemia cases annually in the United States. Despite advances in treatment, disparities in CML mortality persist across different demographic groups, particularly by race, age, sex, and social determinants of health. This study explores mortality trends by race, age, and gender in CML from 1999 to 2020 in the United States. Methods Mortality data for CML (ICD-10 code C92.1) were analyzed from the CDC Wonder Database (1999-2020). Age-adjusted mortality rates (AAMRs) were calculated per 100,000 persons and stratified by sex, race (White and African American), and adult age groups. Results While overall CML mortality rates declined after the introduction of tyrosine kinase inhibitors (TKIs) in 2001, disparities persist. Older adults, males, and African Americans exhibit higher mortality rates compared to their counterparts. African Americans’ AAMR decreased from 0.7 in 1999 to 0.35 by 2008 (annual percent change (APC) of -8.5%, p < 0.01). White Americans had a larger reduction in AAMR, from 0.65 in 1999 to 0.3 by 2007 (APC of -10.0%, p < 0.01). Age-specific analyses highlighted a decrease in mortality across adult age groups. The oldest group, aged ≥85 years, had an AAMR of 5.25 in 1999, which decreased to 4.7 by 2020 but remained significantly higher than other age groups. Conclusions Despite the effectiveness of TKIs, significant disparities in CML mortality remain, particularly among older adults, males, and African Americans. Addressing these disparities requires a multifaceted approach, including better access to care, increased representation in clinical trials, and tailored interventions for each demographic group, which is critical to reducing these disparities and improving outcomes for all patients.

  • Open Access

    Breast Cancer Recurrence After 46 Years of Remission: A Case Report and Clinical Implications

    by Heena Parkash, Aarifah Bandealy, Saad Rashid, Abhinav Kakuturu, Yousuf Parekh, Zeeshan Muzammil, Manzer Ali, Haleem Rasool

    Breast cancer is the most commonly diagnosed malignancy among women worldwide. While survival outcomes have improved substantially over time, recurrence remains a significant concern, especially in estrogen receptor-positive (ER+) disease. Although most recurrences occur within five years of initial treatment, ER+ tumors carry a persistent risk of late relapse due to tumor dormancy. Very late recurrences occurring decades after remission are rare and poorly characterized. We present the case of a 96-year-old female with a history of right-sided breast cancer treated with mastectomy and adjuvant radiation therapy at age 50, who presented 46 years later with a palpable chest wall mass near her prior mastectomy scar. Imaging revealed an irregular hypoechoic lesion extending into the pectoralis muscle (BIRADS-5). Core biopsy demonstrated moderately differentiated infiltrating lobular carcinoma that was strongly ER+, progesterone receptor-negative, and HER2 non-amplified. Staging studies revealed no evidence of distant metastatic disease. Given the patient's advanced age, comorbidities, and prior radiation exposure, surgical and radiation approaches were deferred. Following multidisciplinary tumor board discussion and shared decision-making, primary endocrine therapy with tamoxifen was initiated. The patient demonstrated clinical regression within three months and tolerated therapy well. This case represents one of the longest reported intervals between initial remission and breast cancer recurrence, highlighting the prolonged biologic potential of dormant ER-positive tumor cells. Clinicians should maintain vigilance for recurrence even decades after treatment, particularly in hormone receptor-positive disease.

  • Open Access

    A case of Anti-Hu and Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with stage IV adenocarcinoma of Müllerian origin

    by Saad Rashid, Suneha Pocha, Nada Saleh, Erin Ozminkowski, Vijayta Geeta Bansal, Vibhav Bansal


  • Open Access

    A Case of Non-islet Cell Tumor Hypoglycemia Secondary to Metastatic Rectal Adenocarcinoma: Presentation, Management, and Literature Review

    by Saad Rashid, Heena Parkash, Zeeshan Muzammil, Sultan Ahmed, Mohammed Zaman, Mohammed Ahmed Khan, Nadia Hrynewycz

    Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome associated with a variety of benign and malignant tumors. It is most commonly associated with tumors of epithelial or mesenchymal origin. Management of NICTH primarily involves resection of the underlying tumor, along with other therapies. We report a case of NICTH secondary to metastatic rectal adenocarcinoma. While NICTH has previously been associated with colorectal cancers, few cases (if any) have been reported in patients with primary rectal cancer. We present the case of a 51-year-old male with a medical history of pre-diabetes, gastroesophageal reflux disease, and tobacco use disorder. He was admitted for evaluation of rapid weight loss and was found to have rectal thickening, along with lesions in the lungs, liver, pancreas, and other sites, raising concern for metastasis. He underwent a colonoscopy with biopsy, which confirmed primary rectal adenocarcinoma. During his inpatient stay, he experienced recurrent episodes of hypoglycemia. A diagnosis of NICTH was supported by the low levels of pro-insulin, insulin, C-peptide, IGF-I and an elevated IGF-II:IGF-I ratio. The patient was treated with corticosteroids, glucagon, continuous dextrose infusions, and parenteral nutrition to manage hypoglycemia. This case highlights the importance of considering NICTH in the differential diagnosis for patients with unexplained or refractory hypoglycemia, especially when a notable mass or malignancy is suspected. It also highlights the need for a multimodal approach in managing the underlying hypoglycemia.

  • Open Access

    A Case of Infraorbital B‐cell Lymphoma Masquerading as an Abscess

    by Saad Rashid, Mudassar Sandozi, Saagar Pamulapati, Ajay Doniparthi, Suneha Pocha, Mohammed Ahmed Khan

    Background/Aim: Primary ocular adnexal lymphomas pose a diagnostic challenge for physicians due to their nonspecific symptom presentation and resemblance to other periorbital masses, such as skin and soft tissue infections. Early diagnosis and appropriate management are crucial for optimizing outcomes and coordination of therapy. Case Report: We present a case of a 67-year-old male with a history of infraorbital trauma, initially managed as a soft tissue infection, which was later revealed to be a large B-cell lymphoma. Despite multiple specialty evaluations, including dermatology, ophthalmology, plastic surgery, and ENT, among others, diagnosis was delayed, leading to worsening symptoms and vision impairment. Conclusion: This case highlights the importance of considering ocular adnexal lymphomas in the differential diagnosis of periorbital masses and the need for interdisciplinary collaboration for timely recognition and treatment.

  • Open Access

    A Challenging Decision: Identifying and Managing Hepatic Hydrothorax in the Setting of a Pancreatic Neuroendocrine Tumor

    by Sultan Ahmed, Ayaz Gen, Abu Fahad Abbasi, Saad Rashid, Sanya Siraj, Altaf Dawood

    Neuroendocrine tumors (NETs) are rare neoplasms composed of neuroendocrine cells and seen in approximately 2% of malignancies in the United States. These are often underdiagnosed due to nonspecific presentations early in the disease course. Although found primarily in the gastrointestinal tract, lungs, and pancreas, these tumors can be seen anywhere in the body. The following case highlights an unusual presentation of a NET and subsequent management of hepatic hydrothorax in the setting of obstruction rather than decompensated liver cirrhosis.

  • Open Access

    Leveraging Saliva for Insights into Head and Neck Cancer

    by Saad Rashid, Prashant Puttagunta, Saagar Pamulapati, Jianqiang Yang, Suneha Pocha, Nabil F. Saba, Yong Teng

    Head and neck cancer (HNC) represents a heterogeneous group of malignancies with increasing global incidence and notable mortality. Early detection is essential for improving survival rates and minimizing recurrence; however, existing diagnostic methods are often invasive and complex. There is a need for noninvasive and more effective approaches for early detection and real-time monitoring of HNC. Saliva contains various biomolecules that may serve as indicators of HNC. As a result, saliva-based biomarkers have emerged as a transformative approach in the diagnosis and treatment of HNC due to their ease of collection, non-invasiveness, and potential to provide details about biomolecular changes associated with cancer progression. This narrative review synthesizes the current literature on the potential of saliva as a noninvasive diagnostic tool for HNC. It highlights various biomarkers found in saliva, including cell-free DNA, RNA, proteins, and metabolites, and explores emerging technologies in saliva detection that could transform the future of HNC management. Continued research efforts and larger-scale validation studies are essential to fully realize the potential of saliva-based biopsy and help pinpoint notable biomarkers to improve patient outcomes and reduce mortality associated with HNC worldwide.


  • Open Access

    A Case of Thrombotic Microangiopathy Secondary to Hypertensive Emergency: Presentation, Management, and Distinguishing Features

    by Saad Rashid, Sultan Ahmed, Mohammed Ahmed Khan

    Thrombotic microangiopathies (TMA) are a group of conditions that present with varying degrees of microthrombi, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction, and neurological impairment. Etiologies can be primary, such as thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and atypical hemolytic uremic syndrome (aHUS), or secondary, such as due to systemic infections, malignancies, immune-mediated conditions, and hypertensive emergencies. In hypertensive emergencies, this presentation can occur from mechanical stress placed on red blood cells as they pass through narrowed arteries due to edema and microangiopathic changes within the vessels themselves. In TMA secondary to hypertensive emergencies (HTN-TMA), blood pressure control alone can lead to improvement in cytopenias.